An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear medicine imaging agent targeting copper accumulation in tumors can detect prostate cancer recurrence early in patients with biochemical relapse (rising prostate-specific antigen [PSA] level).

Turning 40 is a benchmark birthday for many women in the United States. While a pessimist might view it as a signal that their glory days are over, more and more women are optimistic about the milestone, seeing it as a kickoff into the best years of their lives. But one thing is true for all women – health needs and preventative wellness routines should begin to change at age 40.

OptiStar Elite injector

The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual growth rate (CAGR) of 5.8 percent, according to a new report by Grand View Research, Inc., a research firm based in San Francisco. Rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period. These devices assist surgeons in accurate insertion of contrast agents with reduced human errors, thus increasing the accuracy and efficiency of surgical procedures. They play a crucial role in intra-operative computed tomography (iCT), intra-operative magnetic resonance imaging (iMRI) and interventional cardiology. Availability of advanced injector systems for diagnosis and intra-operative imaging has boosted adoption of these systems.
Fujifilm introduced a DBT option to the Aspire Cristalle full-field digital mammography (FFDM) system in 2017 following FDA approval for the upgrade.

In the world of breast imaging, digital breast tomosynthesis (DBT) is a relative newcomer, only being adopted into clinical practice in the last 8 years. The benefits of DBT, also known as 3-D mammography, are generally understood — improved cancer detection over traditional 2-D mammography due to the ability to scroll through different slices of the breast to see lesions undetectable in two dimensions. While the evidence for DBT has been mounting, new data reveal the technology has seen explosive growth in the last 18 months.

Fysicon announced its acquisition by Canon Medical Systems Corporation. Linda Elberse, CEO of Fysicon, stated: "Being part of a major player as Canon Medical Systems Corporation gives us the opportunity to cover all parts of the world with our innovative systems. Now Canon Medical has completed the image by adding Fysicon’s new developed hemodynamic monitoring system “QMAPP”, the sophisticated device management system “DataLinQ” and the cloud based image distribution software “EVOCS" and last but not least Fysicon's knowledge of connectivity and workflow management. Canon Medical is a strong brand name and a leading supplier, which will help us take the next steps into strengthening and growing our footprint in the global market. Furthermore we will keep developing new technologies and exploring new areas in the medical field together with our new parent company. We are very proud to have joined forces!”

Moral ambiguities don’t often come into play in medical imaging. Forget what Dr. House says ad nauseam on the syndicated doctor show. Nobody does exploratory surgery anymore. Seeing inside the body noninvasively is … duh!

Another benefit of tomosynthesis is reducing patients’ radiation exposure, which is especially important if they need additional testing.

Technological advances — particularly the adoption of 3-D digital breast tomosynthesis (DBT) — are making it possible for earlier, and more accurate, detection of breast cancer. However, the transition to 3-D mammography is resulting in numerous challenges and concerns. DBT produces hundreds of images, compared to just four images typically associated with conventional 2-D digital mammography. As a result, radiologists find they require significantly more time to review and interpret each exam, reducing the number of patients they can see each day and increasing fatigue, which could potentially lead to missed diagnoses.

Located in a spacious 25,000-square-foot facility on the Presbyterian Hospital of Dallas campus, Southwest Diagnostic Imaging Center is one of the largest freestanding imaging centers in the Dallas-Fort Worth area. Since 1985, the facility has provided thousands of patients from Texas and across the nation with the highest standard of service and a patient-centered approach to care.

As one of the largest Catholic, not-for-profit healthcare systems in the United States, St. Louis-based SSM Health has expanded immensely over the years. So, too, has its ability to apply innovative imaging solutions that meet the needs of it growing patient base. One of the largest integrated delivery systems in the nation, SSM Health serves the comprehensive health needs of communities across the Midwest, with facilities in Illinois, Missouri, Oklahoma and Wisconsin.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent months. Market research firm MEDraysintell released a new report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now